Parenteral dosage form of diltiazem
US11241379B2 · kind B2 · utility
1Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 2016 |
| Grant date | Feb 8, 2022 |
| Priority date | — |
| Expiry date | Feb 4, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a parenteral dosage form comprising a) a ready-to-infuse, stable aqueous solution comprising diltiazem or its pharmaceutically acceptable salt, pH adjusting agent to provide a pH in the range of 3 to 5 and ethanol, and b) an infusion container filled with said aqueous solution.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.